Iodine supplements for Graves' hyperthyroidism
Part of Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether adding iodine supplements to standard treatment helps control thyroid hormone levels in people with Graves' hyperthyroidism. It is for people who are either newly diagnosed or still have high hormone levels despite treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are newly diagnosed with Graves' hyperthyroidism and haven't started treatment yet.
- Or you are on antithyroid medication for less than 3 months and still have high thyroid hormone levels with a positive TRAb test.
- Or you've been on antithyroid medication for over 3 months but haven't taken it regularly and still have high hormone levels with a positive TRAb test.
- Your thyroid gland is not severely enlarged (grade 3)
- Your TRAb level is not above 40 IU/L
- You do not have moderate or severe thyroid eye disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking Lugol’s iodine solution before thyroid surgery is safe and helpful for people with Graves’ disease or toxic nodular goiter (overactive thyroid). It may be aimed at improving surgical readiness and outcomes by reducing thyroid activity before the operation.
This trial tests an investigational drug called IMVT-1402 for people with Graves' disease whose thyroid is still overactive even while taking standard antithyroid medication. The goal is to see if the drug can better control thyroid hormone levels.
This trial tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking antithyroid medication. The goal is to see if the drug can safely help control thyroid hormone levels.
This study tests efgartigimod, a new medicine given by injection under the skin, to see if it can help control Graves' disease (an overactive thyroid condition). The goal is to reduce the need for other thyroid medications or help people stop taking them.
This study compares different treatment plans to see how well they control Graves’ disease and whether it comes back. It may help by identifying which approach works best to prevent relapse.
This trial tests a new medicine called REGN24493 that may help control Graves' disease by blocking a specific receptor in the body. It is designed for adults who have been diagnosed with Graves' disease and are currently stable on their thyroid levels.
Hear when a new Graves Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.